ARTICLE;
CLINICAL COMPETENCE;
CLINICAL PATHWAY;
CONTRACEPTION;
CONTRACEPTIVE DEVICE;
DEVICE REMOVAL;
FUNDING;
HEALTH CARE COST;
HEALTH CARE QUALITY;
HEALTH PRACTITIONER;
HUMAN;
LAW SUIT;
NATIONAL HEALTH SERVICE;
PATIENT REFERRAL;
PRACTICE GUIDELINE;
PRIMARY MEDICAL CARE;
RISK MANAGEMENT;
UNITED KINGDOM;
DRUG IMPLANT;
FEMALE;
PROCEDURES;
CONTRACEPTIVE AGENT;
DESOGESTREL;
DRUG IMPLANT;
ETONOGESTREL;
CONTRACEPTIVE AGENTS, FEMALE;
DESOGESTREL;
DEVICE REMOVAL;
DRUG IMPLANTS;
FEMALE;
GREAT BRITAIN;
HUMANS;
Mansour D, Walling M, Glenn D, Egarter C, Graesslin O, Herbst J, et al. Removal of non-palpable etonogestrel implants. J Fam Plann Reprod Health Care 2008; 34: 89-91.
Methods of accurate localisation of non-palpable subdermal contraceptive implants
Mansour D, Fraser IS, Walling M, Glenn D, Graesslin O, Egarter C, et al. Methods of accurate localisation of non-palpable subdermal contraceptive implants. J Fam Plann Reprod Health Care 2008; 34: 9-12.
Location and removal of non-palpable lmplanon® implants with the aid of ultrasound guidance
Singh M, Mansour D, Richardson D. Location and removal of non-palpable lmplanon® implants with the aid of ultrasound guidance. J Fam Plann Reprod Health Care 2006; 32: 153-156.
Organon Laboratories Ltd. Implanon 68mg implant for subdermal use updated 14 July, Accessed 1 November 2008
Organon Laboratories Ltd. Implanon 68mg implant for subdermal use (updated 14 July 2008). http://emc.medicines.org.uk/emc/assets/c/html/ DisplayDoc.asp?DocumentID=5382 [Accessed 1 November 2008].
(2008)
9
33746297421
Why go to Tiger Country? A report of two cases of Implanon® removal
Webb AMC. Why go to Tiger Country? A report of two cases of Implanon® removal. J Fam Plann Reprod Health Care 2006; 32: 193-194.
Organon Laboratories Ltd. Guidance to the revised SMPC for Implanon Leaflet, September
Organon Laboratories Ltd. Guidance to the revised SMPC for Implanon (Leaflet). September 2008.
(2008)
11
84925561897
National Collaborating Centre for Women's and Children's Health. Commissioned by the National Institute for Health and Clinical Excellence. Long-Acting Reversible Contraception (Guideline 30). http://www.nice.org.uk/CG030 [Accessed 1 November 2008].
National Collaborating Centre for Women's and Children's Health. Commissioned by the National Institute for Health and Clinical Excellence. Long-Acting Reversible Contraception (Guideline 30). http://www.nice.org.uk/CG030 [Accessed 1 November 2008].
12
84925569447
24 June 2008, Accessed 1 November 2008
Department of Health. Statement on Contraception and Teenage Pregnancy. 24 June 2008. http://www.dh.gov.uk/en/Publichealth/ Healthimprovement/Sexualhealth/DH_085686 [Accessed 1 November 2008].